Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Carol Langford, MD, MHS, FACP

216.444.5632

Carol Langford, MD, MHS, FACP
Department: Rheumatologic and Immunologic Disease
Director, Center for Vasculitis Care and Research
Location: Cleveland Clinic Main Campus
Mail Code A50
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5632
DeskDesk:216.445.6056
WorkFax:216.445.7569
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Carol A. Langford, MD, MHS, FACP, received her medical degree at the University of California Los Angeles in 1987 and trained in internal medicine at the University of Michigan from 1987 to 1990. She was a fellow in rheumatology at Duke University Medical Center from 1990 to 1994. In 1995, she received a Master's Degree in health sciences from Duke University in order to pursue a career in clinical investigation.

From 1994 to 2004, Dr. Langford was a senior investigator within the Immunologic Diseases Section of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). At the NIH, Dr. Langford’s research focused on vasculitic diseases, where she was Principal Investigator for nine vasculitis-related protocols. From 1999 to 2002, Dr. Langford served as Chairman of the NIAID Institutional Review Board in supporting the protection of human subjects. While at the NIH, Dr. Langford received an NIAID Special Act of Service Award in 2001 and was the recipient of NIAID Staff Recognition Awards from 1998 through 2004.

In 2004, Dr. Langford joined Cleveland Clinic to become Director of the Center for Vasculitis Care and Research within the Department of Rheumatic and Immunologic Diseases. She is an Associate Professor of Medicine of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and was named Vice-Chair of Rheumatology for Research in 2007.

At Cleveland Clinic, Dr. Langford’s work has continued to focus on patient care and research in vasculitic diseases, including Wegener’s granulomatosis, giant cell arteritis, Takayasu’s arteritis, polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and other forms of vasculitis. In 2007, she was awarded an important research contract from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH for concurrent pilot studies in giant cell arteritis and Takayasu’s arteritis. She has additionally received funding from the Rare Diseases Clinical Research Network of the NIH to conduct studies in Wegener’s granulomatosis. These studies will be conducted in partnership with colleagues in the Vasculitis Clinical Research Consortium, a collaborative research network funded by the NIH.

Dr. Langford is an active member of the American College of Rheumatology, where she has served on several committees. She was an Associate Editor for Arthritis and Rheumatism, a leading journal in rheumatology, from 2000 to 2005. Dr. Langford serves as a consultant to the Vasculitis Foundation. For the last two years, she has been named one of Cleveland’s Top Doctors by Cleveland magazine.

A frequently invited lecturer at national and international medical meetings, Dr. Langford has authored more than 50 scientific papers and chapters on vasculitis. She is Co-Editor with Anthony Fauci, MD, for Harrison’s Rheumatology taken from Harrisons’s Principles of Internal Medicine.

Professional Highlights

  • Research Contract Award, NIAMS, National Institutes of Health, 2007-2012, Principal Investigator for a study entitled “Concurrent Pilot Studies in Giant Cell Arteritis (GCA) and Takayasu’s arteritis (TAK) to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis.”
  • Director, Center for Vasculitis Care and Research, Cleveland Clinic, 2004-Present
  • Vice-Chair, Rheumatology for Research, Cleveland Clinic, 2007-Present
  • Senior Investigator, NIAID, National Institutes of Health, 1994-2004
  • Chair, Institutional Review Board, NIAID, National Institutes of Health, 1999-2002

Education & Fellowships

Graduate - Duke University
Durham, NC USA
1995
Fellowship - Duke University Medical Center
Rheumatology
Durham, NC USA
1994
Residency - University of Michigan Health System
Internal Medicine
Ann Arbor, MI USA
1990
Internship - University of Michigan Health System
Internal Medicine
Ann Arbor, MI USA
1988
Medical School - University of California-Los Angeles School of Medicine
Los Angeles, CA USA
1987
Undergraduate - University of California-Riverside
Riverside, CA USA
1983

Certifications

  • Internal Medicine- Rheumatology

Specialty Interests

Vasculitis

Awards & Honors

  • Research funding, Principal Investigator NIH/NIAMS Contract Award, 2007-2012
  • Top Docs in Cleveland, Cleveland magazine, 2006-2007
  • NIAID Staff Recognition Award, 1998-2004
  • NIAID Special Act of Service Award, 2001
  • UCLA Honors in Internal Medicine, 1987
  • Phi Beta Kappa, 1984   

Additional Training

  • Master of Health Sciences, Duke University, 1995

Memberships

  • American College of Physicians
  • American College of Rheumatology

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/26/2014, Dr. Langford has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Langford receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Annenberg Foundation

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English